Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors

Clinical trial NCT00333502 · COMPLETED

Trial details

NCT number: NCT00333502
Sponsor: NewLink Genetics Corporation
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer Solid Tumor

Start date: 2006-05-01
Primary completion: 2011-11-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.